Reversed Expression of JAK/STAT Pathway Proteins in Breast Cells
Author Information
Author(s): Gary L. Bratthauer, Brian L. Strauss, Ross Barner
Primary Institution: Armed Forces Institute of Pathology
Hypothesis
Does the JAK/STAT pathway disturbance play a role in abnormal breast cell growth?
Conclusion
The study found that normal breast cells express STAT5a while abnormal cells often express PRLR instead, indicating a potential signaling pathway disturbance.
Supporting Evidence
- STAT5a is expressed in over 80% of normal breast cell nuclei.
- PRLR is minimally detected in normal breast cells but abundantly expressed in cancerous cells lacking STAT5a.
- Secretory carcinomas retain STAT5a expression, differing from other breast cancer types.
Takeaway
In healthy breast cells, a protein called STAT5a is present, but in cancerous cells, another protein called PRLR takes its place, which might be a sign of something going wrong.
Methodology
The study used immunohistochemistry to analyze the expression of PRLR and STAT5a in various breast tissue samples.
Limitations
The study is limited to the analysis of specific breast tissue samples and may not represent all breast cancer types.
Want to read the original?
Access the complete publication on the publisher's website